dvantagene   

Advantagene is a privately held biopharmaceutical company focused on oncology and immunotherapy based in Auburndale, Massachusetts, just outside of Boston. Since its founding in 1999, the company has advanced its lead clinical programs through Phase 2 and is entering Phase 3. The company is funded by private investors and grants from National Institutes of Health.

The management team has extensive experience in product development, biologics regulatory and manufacturing. The team was directly involved in the early development of this novel technology.